These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32126366)

  • 21. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
    Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
    J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages.
    May TW; Helmer R; Bien CG; Brandt C
    Ther Drug Monit; 2018 Oct; 40(5):620-627. PubMed ID: 30086089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial.
    Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S;
    Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
    Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
    Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center.
    Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH
    Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacosamide serum concentrations during pregnancy.
    Zutshi D; Millis SR; Basha MM; Daimee MA; Srinivas M
    Epilepsy Behav; 2021 Oct; 123():108253. PubMed ID: 34399392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.
    Maschio M; Dinapoli L; Mingoia M; Sperati F; Pace A; Pompili A; Carapella CM; Vidiri A; Muti P
    J Neurol; 2011 Nov; 258(11):2100-4. PubMed ID: 21674196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting.
    Tateishi Y; Ishikawa N; Kobayashi Y; Izumo H; Eguchi Y; Okada S
    Epilepsy Res; 2022 Nov; 187():107030. PubMed ID: 36308995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice.
    Shandra A; Shandra P; Kaschenko O; Matagne A; Stöhr T
    Epilepsia; 2013 Jul; 54(7):1167-75. PubMed ID: 23750855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the correlations of lacosamide concentrations in saliva and serum in patients with epilepsy.
    Brandt C; Bien CG; Helmer R; May TW
    Epilepsia; 2018 Apr; 59(4):e34-e39. PubMed ID: 29450894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients.
    Böttcher S; Lutz MT; Mayer T
    Epilepsia; 2017 Oct; 58(10):1749-1754. PubMed ID: 28804872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Russian experience of lacosamide (vimpat) usage in treatment of uncontrolled focal epilepsy].
    Lebedeva AV; Burd SG; Belyaev OV; Vlasov PN; Dorofeeva MY; Ismailov AM; Kissin MY; Kovaleva IY; Koroleva NY; Lipatova LV; Mukhin KY; Solomatin YV; Chervyakov AV; Shikhkerimov RG; Pylaeva OA; Freidkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):74-81. PubMed ID: 28005051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience combined with therapeutic drug monitoring of lacosamide.
    Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
    Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of lacosamide in the intensive care unit.
    Cherry S; Judd L; Muniz JC; Elzawahry H; LaRoche S
    Neurocrit Care; 2012 Apr; 16(2):294-8. PubMed ID: 22203547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of lacosamide monotherapy on sleep architecture in patients with epilepsy: a preliminary evidence.
    Lupo C; Fernandes M; Spanetta M; Sarbu OE; Carnovale C; Di Gioia B; Placidi F; Izzi F; Mercuri NB; Liguori C
    J Neural Transm (Vienna); 2023 Feb; 130(2):87-95. PubMed ID: 36592241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study.
    Kalilani L; Lu C; Pierre-Louis B; Gold M
    Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.